Back

MRPL44 haploinsufficient mouse spontaneously develops hypertrophic cardiomyopathy and shows systolic dysfunction after aldosterone treatment

2 September 2024 (09:50 - 10:00)
Organised by: Logo
Congress Presentation Part of: Novel mechanisms in arrhythmogenic cardiac diseases Cardiomyopathies ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Ryuji Okamoto

Mie University Graduate School of Medicine, Tsu (Japan)

4 More presentations in this session

Presentation thumbnail
Reduced Na current in dystrophin-deficient ventricular cardiomyocytes is rescued by tenascin-C inhibition
Ms J. Marksteiner (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
A novel murine model of stress-induced cardiomyopathy achieved by chemogenetic stimulation of the locus coeruleus-norepinephrine system
Doctor S. Ministrini (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Phosphoproteomics of PLN R14del heart tissue reveals major myocyte degenerate phenotype, and is attenuated by PLN antisense treatment in vitro
Mr F. Deiman (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Burst-like transcription of MYH7, allelic and contractile imbalance already in early stage hiPSC-cardiomyocytes indicate these as pathogenic factors in Hypertrophic Cardiomyopathy
Doctor T. Kraft (Hannover, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Novel mechanisms in arrhythmogenic cardiac diseases
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 09:50 CET
You may be interested in
thumbnail
Congress Session
Novel mechanisms in arrhythmogenic cardiac diseases
thumbnail
Congress Presentation
Mitochondrial cardiomyopathy
thumbnail
Congress Presentation
The H222P-Lamin mutation induces heart failure via impaired mitochondrial calcium uptake in human cardiac laminopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources